(Q45422546)

14 December 2017

Herpes simplex virus type 1 mutant HF10 oncolytic viral therapy for bladder cancer (English)

1 reference

Herpes simplex virus type 1

14 December 2017

1 reference

1 reference

5

Tetsutaro Sata

1 reference

14 December 2017

Shin-ichi Kohno

1

1 reference

14 December 2017

Chenhong Luo

2

1 reference

14 December 2017

Fumi Goshima

3

1 reference

14 December 2017

Yukihiro Nishiyama

4

1 reference

14 December 2017

Yoshinari Ono

6

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

14 December 2017

1 reference

14 December 2017

66

1 reference

14 December 2017

5

1 reference

14 December 2017

1116-1121

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.041

14 December 2017

1 reference

Herpes simplex virus gene products: the accessories reflect her lifestyle well

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.041

Oncolytic viral therapy using a spontaneously generated herpes simplex virus type 1 variant for disseminated peritoneal tumor in immunocompetent mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.041

Oncolytic viral therapy for breast cancer with herpes simplex virus type 1 mutant HF 10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.041

Treatment of solid sarcomas in immunocompetent mice with novel, oncolytic herpes simplex viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.041

Intratumoral injection of herpes simplex virus HF10 in recurrent breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.041

Oncolytic herpes simplex virus vectors for cancer virotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.041

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.041

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.041

The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.041

Intralesional injection of herpes simplex virus 1716 in metastatic melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.041

Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.041

Intravesical and intravenous therapy of human bladder cancer by the herpes vector G207

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.041

A sequence in HpaI-P fragment of herpes simplex virus-1 DNA determines intraperitoneal virulence in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.041

Herpes simplex virus type 1 (HSV-1) UL56 gene is involved in viral intraperitoneal pathogenicity to immunocompetent mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.041

Identification and characterization of the UL56 gene product of herpes simplex virus type 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.041

Infections with herpes simplex viruses (2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.041

Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.041

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UROLOGY.2005.05.041

1 reference

14 December 2017

1 reference